Market Cap 1.33B
Revenue (ttm) 3.24B
Net Income (ttm) -70.79M
EPS (ttm) N/A
PE Ratio 26.35
Forward PE 12.34
Profit Margin -2.18%
Debt to Equity Ratio 1.14
Volume 1,985,800
Avg Vol 1,230,324
Day's Range N/A - N/A
Shares Out 135.92M
Stochastic %K 99%
Beta 1.76
Analysts Strong Sell
Price Target $12.88

Company Profile

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation...

Industry: Medical Devices
Sector: Healthcare
Phone: 610 424 4515
Address:
555 East North Lane, Suite 5075, Conshohocken, United States
AlertsAndNews
AlertsAndNews Mar. 13 at 2:37 AM
$AHCO quite the insider 10%+ buy here Richard M. Cashin Jr. (10%+) purchased 2,046,691 shares at an average price of $9.73 (Form 4).
0 · Reply
KhokPiSDP
KhokPiSDP Mar. 13 at 1:14 AM
$AHCO Long hold will great 🚀🚀🚀
0 · Reply
TeresaTrades
TeresaTrades Mar. 10 at 1:31 PM
Largest PUT OI decreases $AMZN $NVDA $AMD $AHCO $AVGO
0 · Reply
11thestate
11thestate Mar. 9 at 12:26 PM
Imagine buying $AHCO at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $AHCO investors out there, we’ve got some important news for you: https://11th.com/cases/adapthealth-investor-settlement
0 · Reply
11thestate
11thestate Feb. 26 at 2:58 PM
Don't forget that there is also an important settlement to watch for $AHCO We have every detail, including how investors can get paid: https://11th.com/cases/adapthealth-investor-settlement
0 · Reply
d_risk
d_risk Feb. 24 at 10:58 PM
$AHCO - AdaptHealth Corp - 10K - Updated Risk Factors AHCO’s 10-K adds a wide slate of new risks: concentrated suppliers and vulnerable supply chain, inflation and interest-rate pressure, growing dependence on complex IT and AI with cyber/privacy exposure, tighter and renegotiable public/private payor reimbursement, capitation and collections risk, intense competition and tech obsolescence in sleep/respiratory/diabetes, leverage and liquidity constraints, heavier regulatory, fraud/abuse, climate and oxygen-transport compliance burdens, plus governance overhangs from major holders, a TRA, no planned dividends, and Delaware forum limits. 🟢 Added 🟠 Removed https://d-risk.ai/AHCO/10-K/2026-02-24
0 · Reply
healthcareguru
healthcareguru Feb. 24 at 3:22 PM
$AHCO Easy Buying oppty on 4Q noise but 2026 outlook ahead… 👍
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 24 at 12:18 PM
$AHCO Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.76 down -323.53% YoY • Reported revenue of $846.29M down -1.21% YoY • AdaptHealth provides fiscal year 2026 guidance, expecting net revenue between $3.44B and $3.51B. Adjusted EBITDA is projected to be $680M to $730M, with free cash flow of $175M to $225M.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Feb. 24 at 12:11 PM
$AHCO AdaptHealth Q4 Sales $846.289M Beat $831.610M Estimate
0 · Reply
DonnaDalke131
DonnaDalke131 Feb. 18 at 12:55 PM
$AHCO Home-based healthcare provider benefiting from demographic trends.
0 · Reply
Latest News on AHCO
AdaptHealth Corp. (AHCO) Q4 2025 Earnings Call Transcript

Feb 24, 2026, 11:17 AM EST - 17 days ago

AdaptHealth Corp. (AHCO) Q4 2025 Earnings Call Transcript


AdaptHealth Corp. Announces Upgraded Moody's Ratings

Jan 27, 2026, 8:00 AM EST - 6 weeks ago

AdaptHealth Corp. Announces Upgraded Moody's Ratings


AdaptHealth Corp. to Participate in Upcoming Investor Conference

Nov 26, 2025, 8:30 AM EST - 3 months ago

AdaptHealth Corp. to Participate in Upcoming Investor Conference


AdaptHealth Corp. (AHCO) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 12:06 PM EST - 4 months ago

AdaptHealth Corp. (AHCO) Q3 2025 Earnings Call Transcript


AdaptHealth Corp. Announces Third Quarter 2025 Results

Nov 4, 2025, 7:00 AM EST - 4 months ago

AdaptHealth Corp. Announces Third Quarter 2025 Results


AdaptHealth Corp. (AHCO) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 11:03 AM EDT - 7 months ago

AdaptHealth Corp. (AHCO) Q2 2025 Earnings Call Transcript


AdaptHealth Corp. Announces Second Quarter 2025 Results

Aug 5, 2025, 7:01 AM EDT - 7 months ago

AdaptHealth Corp. Announces Second Quarter 2025 Results


AdaptHealth Corp. (AHCO) Q1 2025 Earnings Call Transcript

May 6, 2025, 3:51 PM EDT - 11 months ago

AdaptHealth Corp. (AHCO) Q1 2025 Earnings Call Transcript


AdaptHealth Corp. Announces First Quarter 2025 Results

May 6, 2025, 7:00 AM EDT - 11 months ago

AdaptHealth Corp. Announces First Quarter 2025 Results


My Sleep Apnea Has Led Me To Profits With AdaptHealth

Mar 4, 2025, 3:47 AM EST - 1 year ago

My Sleep Apnea Has Led Me To Profits With AdaptHealth


AdaptHealth Corp. (AHCO) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 2:20 PM EST - 1 year ago

AdaptHealth Corp. (AHCO) Q4 2024 Earnings Call Transcript


AdaptHealth Corp. (AHCO) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 1:27 PM EST - 1 year ago

AdaptHealth Corp. (AHCO) Q3 2024 Earnings Call Transcript


AdaptHealth Corp. Announces Third Quarter 2024 Results

Nov 5, 2024, 7:26 AM EST - 1 year ago

AdaptHealth Corp. Announces Third Quarter 2024 Results


AdaptHealth Appoints Diana Nole to Board of Directors

Oct 17, 2024, 8:00 AM EDT - 1 year ago

AdaptHealth Appoints Diana Nole to Board of Directors


AdaptHealth Corp. Announces New Chief Operating Officer

Aug 26, 2024, 7:30 AM EDT - 1 year ago

AdaptHealth Corp. Announces New Chief Operating Officer


AdaptHealth Corp. Announces Second Quarter 2024 Results

Aug 6, 2024, 7:00 AM EDT - 1 year ago

AdaptHealth Corp. Announces Second Quarter 2024 Results


AlertsAndNews
AlertsAndNews Mar. 13 at 2:37 AM
$AHCO quite the insider 10%+ buy here Richard M. Cashin Jr. (10%+) purchased 2,046,691 shares at an average price of $9.73 (Form 4).
0 · Reply
KhokPiSDP
KhokPiSDP Mar. 13 at 1:14 AM
$AHCO Long hold will great 🚀🚀🚀
0 · Reply
TeresaTrades
TeresaTrades Mar. 10 at 1:31 PM
Largest PUT OI decreases $AMZN $NVDA $AMD $AHCO $AVGO
0 · Reply
11thestate
11thestate Mar. 9 at 12:26 PM
Imagine buying $AHCO at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $AHCO investors out there, we’ve got some important news for you: https://11th.com/cases/adapthealth-investor-settlement
0 · Reply
11thestate
11thestate Feb. 26 at 2:58 PM
Don't forget that there is also an important settlement to watch for $AHCO We have every detail, including how investors can get paid: https://11th.com/cases/adapthealth-investor-settlement
0 · Reply
d_risk
d_risk Feb. 24 at 10:58 PM
$AHCO - AdaptHealth Corp - 10K - Updated Risk Factors AHCO’s 10-K adds a wide slate of new risks: concentrated suppliers and vulnerable supply chain, inflation and interest-rate pressure, growing dependence on complex IT and AI with cyber/privacy exposure, tighter and renegotiable public/private payor reimbursement, capitation and collections risk, intense competition and tech obsolescence in sleep/respiratory/diabetes, leverage and liquidity constraints, heavier regulatory, fraud/abuse, climate and oxygen-transport compliance burdens, plus governance overhangs from major holders, a TRA, no planned dividends, and Delaware forum limits. 🟢 Added 🟠 Removed https://d-risk.ai/AHCO/10-K/2026-02-24
0 · Reply
healthcareguru
healthcareguru Feb. 24 at 3:22 PM
$AHCO Easy Buying oppty on 4Q noise but 2026 outlook ahead… 👍
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 24 at 12:18 PM
$AHCO Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.76 down -323.53% YoY • Reported revenue of $846.29M down -1.21% YoY • AdaptHealth provides fiscal year 2026 guidance, expecting net revenue between $3.44B and $3.51B. Adjusted EBITDA is projected to be $680M to $730M, with free cash flow of $175M to $225M.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Feb. 24 at 12:11 PM
$AHCO AdaptHealth Q4 Sales $846.289M Beat $831.610M Estimate
0 · Reply
DonnaDalke131
DonnaDalke131 Feb. 18 at 12:55 PM
$AHCO Home-based healthcare provider benefiting from demographic trends.
0 · Reply
11thestate
11thestate Feb. 17 at 1:43 PM
$AHCO has agreed to settle with investors and call option holders over claims that it overstated its organic growth trajectory by retroactively inflating past growth numbers without proper disclosure. Who’s eligible? Anyone who purchased $AHCO shares or call options between November 8, 2019 and July 16, 2021. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.63 — but normally only ~25% of eligible investors file, the effective payout could increase to $2.52. Can I still file? Yes — late claims are currently being considered for compensation, subject to approval. When do payouts happen? Typically within 8–12 months after court approval of the settlement and completion of the stock distribution component. To file your claim: https://11th.com/cases/adapthealth-investor-settlement
0 · Reply
nWhiteface
nWhiteface Feb. 5 at 12:48 AM
$AHCO she looks ready to go. Taking small position tomorrow
0 · Reply
GammaCrown
GammaCrown Feb. 4 at 2:11 PM
$AHCO is a medical device company focused on ear, nose, and throat products; its growth is driven by new product launches and surgeon adoption.
0 · Reply
11thestate
11thestate Feb. 4 at 1:04 PM
Imagine buying $AHCO at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $AHCO investors out there, we’ve got some important news for you: https://11th.com/cases/adapthealth-investor-settlement
0 · Reply
DanaBlack
DanaBlack Jan. 22 at 11:07 PM
$CAH is getting dropped as a medical supply client by KAISER PERMANENTE and is now going to be doing business with $AHCO! March earnings should be explosive! Source: KP employee!
2 · Reply
11thestate
11thestate Jan. 14 at 1:51 PM
$AHCO has agreed to settle with investors over claims that it overstated its organic growth trajectory by retroactively inflating prior growth figures without proper disclosure. Who’s eligible? Anyone who purchased $AHCO shares between November 8, 2019 and July 16, 2021. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.63 — but if only ~25% of eligible investors file, the effective payout could increase to $2.52. Can I still file? Yes — late claims are being considered, subject to court approval. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/adapthealth-investor-settlement
0 · Reply
11thestate
11thestate Jan. 2 at 3:02 PM
Imagine buying $AHCO at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $AHCO investors out there, we’ve got some important news for you: https://11th.com/cases/adapthealth-investor-settlement
0 · Reply
OptionRunners
OptionRunners Dec. 26 at 8:48 PM
$AHCO trader sold (to close) the January 16th $12.50 puts 20,374 times for $2.35 and bought (to open) the March 20th $12.50 puts (ITM) 20,374 times for $2.44. The trader is rolling the puts out for a $0.09 debit.
0 · Reply
SequencingSage
SequencingSage Dec. 26 at 12:59 PM
$AHCO Expectations are recalibrating toward pragmatic delivery instead of lofty projections. Capital allocation choices will reveal true priorities. Demonstrated durability would lengthen investor time horizons. Without validation, volatility will remain persistent.
0 · Reply
11thestate
11thestate Dec. 24 at 2:11 PM
$AHCO has agreed to settle with investors over claims that it misled them about its revenue growth and Medicare billing practices related to diabetes products. Who’s eligible? Anyone who purchased $AHCO shares between August 4, 2020 and November 7, 2023. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.27 — but if only ~25% of eligible investors file, the effective payout could increase to $1.08. Can I still file? Claim availability depends on the settlement administrator’s approval process. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/adapthealth-investor-lawsuit
0 · Reply
11thestate
11thestate Dec. 22 at 4:49 PM
$AHCO is now accepting claims for a 35M settlement it is paying to investors over claims that it overstated revenue and misrepresented organic growth. If you bought $AHCO between August 4, 2020 and November 7, 2023, you still can file for payment here: https://11th.com/cases/adapthealth-investor-lawsuit
0 · Reply
11thestate
11thestate Dec. 19 at 4:53 PM
With everything going on around $AHCO lately — this is the info you don’t want to miss: https://11th.com/cases/adapthealth-investor-settlement
0 · Reply